CBER Gene Therapy Office To Be Established By Oct. 1

CBER's Office of Cells, Tissues & Gene Therapy will address the "evolution" of scientific and regulatory issues, FDA Center for Biologics Evaluation & Research Director Kathryn Zoon, PhD, said May 29